These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

447 related articles for article (PubMed ID: 28941722)

  • 41. Long noncoding RNA PANDA promotes esophageal squamous carcinoma cell progress by dissociating from NF-YA but interact with SAFA.
    Shi W; Wang Q; Bian Y; Fan Y; Zhou Y; Feng T; Li Z; Cao X
    Pathol Res Pract; 2019 Oct; 215(10):152604. PubMed ID: 31495606
    [TBL] [Abstract][Full Text] [Related]  

  • 42. microRNA-195-Cdc42 axis acts as a prognostic factor of esophageal squamous cell carcinoma.
    Sun N; Ye L; Chang T; Li X; Li X
    Int J Clin Exp Pathol; 2014; 7(10):6871-9. PubMed ID: 25400770
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Serum HOTAIR as a novel diagnostic biomarker for esophageal squamous cell carcinoma.
    Wang W; He X; Zheng Z; Ma X; Hu X; Wu D; Wang M
    Mol Cancer; 2017 Apr; 16(1):75. PubMed ID: 28376832
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Expression of FBXW7 in esophageal squamous cell carcinoma and its clinical significance].
    Yu H; Ling T; Shi R; Shu Q; Li Y; Tan Z
    Zhonghua Zhong Liu Za Zhi; 2015 May; 37(5):347-51. PubMed ID: 26463024
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prognostic significance of FAM3C in esophageal squamous cell carcinoma.
    Zhu YH; Zhang B; Li M; Huang P; Sun J; Fu J; Guan XY
    Diagn Pathol; 2015 Oct; 10():192. PubMed ID: 26498278
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Expression and clinical significance of PI3K in esophageal squamous cell carcinoma].
    Zhang Y; Liu YP; Du K; Wang H; Wang XL
    Zhonghua Zhong Liu Za Zhi; 2011 Aug; 33(8):594-8. PubMed ID: 22325219
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prognostic value of combined and individual expression of microRNA-1290 and its target gene nuclear factor I/X in human esophageal squamous cell carcinoma.
    Xie R; Wu SN; Gao CC; Yang XZ; Wang HG; Zhang JL; Yan W; Ma TH
    Cancer Biomark; 2017 Sep; 20(3):325-331. PubMed ID: 28800311
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Expression of Transcription Factor 21 (TCF21) and Upregulation Its Level Inhibits Invasion and Metastasis in Esophageal Squamous Cell Carcinoma.
    Chen Y; Zhang C; Chen J; Zhang B; Zhang H; Yang X; Liu J; Wu Q
    Med Sci Monit; 2018 Jun; 24():4128-4136. PubMed ID: 29909422
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Low expression of BEX1 predicts poor prognosis in patients with esophageal squamous cell cancer.
    Geng HT; Cheng ZW; Cao RJ; Wang ZB; Xing SZ; Guo C; Wang F; Liu CM; Chen SS; Cheng YF
    Oncol Rep; 2018 Nov; 40(5):2778-2787. PubMed ID: 30132532
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Long non-coding RNA FTH1P3 regulated metastasis and invasion of esophageal squamous cell carcinoma through SP1/NF-kB pathway.
    Yang L; Sun K; Chu J; Qu Y; Zhao X; Yin H; Ming L; Wan J; He F
    Biomed Pharmacother; 2018 Oct; 106():1570-1577. PubMed ID: 30119232
    [TBL] [Abstract][Full Text] [Related]  

  • 51. MicroRNA-1290 promotes esophageal squamous cell carcinoma cell proliferation and metastasis.
    Li M; He XY; Zhang ZM; Li S; Ren LH; Cao RS; Feng YD; Ji YL; Zhao Y; Shi RH
    World J Gastroenterol; 2015 Mar; 21(11):3245-55. PubMed ID: 25805931
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prognostic value of EGFR family expression in lymph node-negative esophageal squamous cell carcinoma patients.
    Yu W; Yang X; Chu L; Zhao K; Chen H; Xiang J; Zhang Y; Li H; Zhao W; Sun M; Wei Q; Fu X; Xie C; Zhu Z
    Pathol Res Pract; 2018 Jul; 214(7):1017-1023. PubMed ID: 29729836
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Effect of miRNA-106a expression on the prognosis of patients with esophageal squamous cell carcinoma].
    Yuan JM; Mao WM; Luo J; Peng BF; Zheng ZG; Ling ZQ
    Zhonghua Zhong Liu Za Zhi; 2013 Aug; 35(8):590-4. PubMed ID: 24314216
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Increased expression of high-mobility group A2: A novel independent indicator of poor prognosis in patients with esophageal squamous cell carcinoma.
    Wei R; Shang Z; Leng J; Cui L
    J Cancer Res Ther; 2016; 12(4):1291-1297. PubMed ID: 28169242
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Upregulation of long noncoding RNA SPRY4-IT1 promotes metastasis of esophageal squamous cell carcinoma via induction of epithelial-mesenchymal transition.
    Zhang CY; Li RK; Qi Y; Li XN; Yang Y; Liu DL; Zhao J; Zhu DY; Wu K; Zhou XD; Zhao S
    Cell Biol Toxicol; 2016 Oct; 32(5):391-401. PubMed ID: 27250657
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Reduced EBP50 expression or mis-localization of the EBP50 protein is associated with the malignant progression of esophageal squamous cell carcinoma.
    Wang L; Du YR; Ji MY; Wang W; Zhan N; Zhou QS; Dong WG
    Eur Rev Med Pharmacol Sci; 2014; 18(24):3854-63. PubMed ID: 25555876
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The expression and significance of HOX transcript antisense RNA and epithelial-mesenchymal transition-related factors in esophageal squamous cell carcinoma.
    Da C; Zhan Y; Li Y; Tan Y; Li R; Wang R
    Mol Med Rep; 2017 Apr; 15(4):1853-1862. PubMed ID: 28260072
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Up-regulation of long noncoding RNA MALAT1 contributes to proliferation and metastasis in esophageal squamous cell carcinoma.
    Hu L; Wu Y; Tan D; Meng H; Wang K; Bai Y; Yang K
    J Exp Clin Cancer Res; 2015 Jan; 34(1):7. PubMed ID: 25613496
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Serum microRNA-15a level acts as a potential diagnostic and prognostic biomarker for human esophageal squamous cell carcinoma.
    Li J; Li M; Gao F; Ge X
    Cancer Biomark; 2017; 18(1):11-17. PubMed ID: 27802201
    [TBL] [Abstract][Full Text] [Related]  

  • 60. High TUG1 expression is associated with chemotherapy resistance and poor prognosis in esophageal squamous cell carcinoma.
    Jiang L; Wang W; Li G; Sun C; Ren Z; Sheng H; Gao H; Wang C; Yu H
    Cancer Chemother Pharmacol; 2016 Aug; 78(2):333-9. PubMed ID: 27329359
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.